1
|
Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.
|
Arthritis Rheum
|
2009
|
1.77
|
2
|
Reactive arthritis: clinical aspects and medical management.
|
Rheum Dis Clin North Am
|
2009
|
1.35
|
3
|
Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections.
|
Microb Pathog
|
2004
|
1.27
|
4
|
Transcriptome profiling of Saccharomyces cerevisiae during a transition from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling.
|
Mol Genet Genomics
|
2006
|
1.26
|
5
|
Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease.
|
J Alzheimers Dis
|
2008
|
1.21
|
6
|
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.
|
Microbes Infect
|
2002
|
1.19
|
7
|
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.
|
Antimicrob Agents Chemother
|
2003
|
1.17
|
8
|
Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice.
|
Immunology
|
2005
|
1.11
|
9
|
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae.
|
Nanomedicine
|
2013
|
1.09
|
10
|
Persistent Chlamydiae and chronic arthritis.
|
Arthritis Res
|
2001
|
1.05
|
11
|
Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain.
|
FEMS Immunol Med Microbiol
|
2006
|
1.03
|
12
|
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae.
|
J Rheumatol
|
2002
|
1.02
|
13
|
Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells.
|
J Infect Dis
|
2002
|
1.01
|
14
|
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis.
|
Mol Pharm
|
2012
|
0.99
|
15
|
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.
|
Immunology
|
2004
|
0.94
|
16
|
Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?
|
J Neuroimmunol
|
2003
|
0.93
|
17
|
Molecular biology of infectious agents in chronic arthritis.
|
Rheum Dis Clin North Am
|
2009
|
0.93
|
18
|
New insights into Chlamydia and arthritis. Promise of a cure?
|
Ann Rheum Dis
|
2013
|
0.93
|
19
|
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
|
Invest Ophthalmol Vis Sci
|
2004
|
0.92
|
20
|
Dendrimer-enabled transformation of Chlamydia trachomatis.
|
Microb Pathog
|
2013
|
0.91
|
21
|
The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype.
|
Microb Pathog
|
2005
|
0.91
|
22
|
Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae.
|
Curr Genet
|
2003
|
0.90
|
23
|
The evolving story of Chlamydia-induced reactive arthritis.
|
Curr Opin Rheumatol
|
2010
|
0.90
|
24
|
The molecular genetic basis of mitochondrial malfunction in bladder tissue following outlet obstruction.
|
J Urol
|
2004
|
0.90
|
25
|
Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.
|
Microb Pathog
|
2009
|
0.89
|
26
|
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced.
|
FEMS Microbiol Lett
|
2008
|
0.89
|
27
|
Spermatogenetic expression of RNA-binding motif protein 7, a protein that interacts with splicing factors.
|
J Androl
|
2003
|
0.85
|
28
|
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.
|
Invest Ophthalmol Vis Sci
|
2007
|
0.84
|
29
|
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
|
Invest Ophthalmol Vis Sci
|
2004
|
0.84
|
30
|
Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype.
|
Am J Med Sci
|
2006
|
0.84
|
31
|
Chlamydia and chronic arthritis.
|
Ann Med
|
2011
|
0.84
|
32
|
Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review.
|
Microbes Infect
|
2002
|
0.83
|
33
|
Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.
|
Int J Med Microbiol
|
2008
|
0.83
|
34
|
Up-regulation of a cellular protein at the translational level by a retrovirus.
|
Proc Natl Acad Sci U S A
|
2008
|
0.83
|
35
|
Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity?
|
Expert Rev Mol Med
|
2006
|
0.82
|
36
|
Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture.
|
Microb Pathog
|
2007
|
0.82
|
37
|
Rsf1p is required for an efficient metabolic shift from fermentative to glycerol-based respiratory growth in S. cerevisiae.
|
Yeast
|
2009
|
0.82
|
38
|
Etiology and pathogenesis of late-onset Alzheimer's disease.
|
Curr Allergy Asthma Rep
|
2014
|
0.81
|
39
|
Regulation of Sam68 activity by small heat shock protein 22.
|
J Cell Biochem
|
2006
|
0.80
|
40
|
Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis.
|
Am J Med Sci
|
2013
|
0.80
|
41
|
The YJR127C/ZMS1 gene product is involved in glycerol-based respiratory growth of the yeast Saccharomyces cerevisiae.
|
Curr Genet
|
2005
|
0.80
|
42
|
Fate of Chlamydophila pneumoniae in human monocyte-derived dendritic cells: long lasting infection.
|
Microb Pathog
|
2006
|
0.80
|
43
|
No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods.
|
J Clin Microbiol
|
2009
|
0.78
|
44
|
The pathogenic role of Chlamydia in spondyloarthritis.
|
Curr Opin Rheumatol
|
2010
|
0.78
|
45
|
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.
|
Int J Clin Rheumtol
|
2012
|
0.78
|
46
|
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.
|
Nanomedicine
|
2011
|
0.78
|
47
|
Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells.
|
Microb Pathog
|
2007
|
0.77
|
48
|
Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysis.
|
J Rheumatol
|
2013
|
0.76
|
49
|
Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain.
|
Pathogenesis (Amst)
|
1999
|
0.76
|
50
|
Seasonal variation in detection of bacterial DNA in arthritic stifle joints of dogs with cranial cruciate ligament rupture using PCR amplification of the 16S rRNA gene.
|
Vet Microbiol
|
2009
|
0.76
|
51
|
Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro.
|
J Microbiol Methods
|
2007
|
0.76
|
52
|
Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.
|
Am J Med Sci
|
2010
|
0.75
|
53
|
Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?
|
Int J Clin Rheumtol
|
2011
|
0.75
|
54
|
Lack of evidence for bacterial infections in skin in patients with systemic sclerosis.
|
Am J Med Sci
|
2009
|
0.75
|
55
|
Cloning of COX4 cDNA from the NZ white rabbit and expression of this gene in bladder smooth muscle following partial outlet obstruction.
|
World J Urol
|
2002
|
0.75
|